Biological treatments

Novel targeted treatments with use of monoclonal antibodies for the efficient and safe therapeutical approach of difficult to treat common chronic dermatological diseases:

  • Psoriasis
  • Atopic dermatitis
  • Hidradenitis suppurativa
  • Chronic Urticaria

Monoclonal antibodies target key chemical substances playing a pivotal role in the inflammation cascade, like TNF and the interleukins 4,12,17,23. This results in a specific inhibition of the underlying pathogenetic mechanism without the systemic immunosuppression and the broad side effects of classical immunosuppressive treatments.

Our clinical expertise and the harmonization with current international clinical guidelines promise an efficient and up-to-date  patient-tailored treatment with maximum safety.